Miss Anca Breahna, PhD, MSc, FEBOPRAS, FRCS (Plast), is a Consultant Plastic & Reconstructive Surgeon in North West England, UK. Menopause does not change the breast implant itself, but it can alter the natural tissues surrounding it and make the breasts look or feel different over time.
Hormonal changes may reduce breast density, soften glandular tissue, affect skin elasticity, alter fat distribution, and contribute to breast descent. The implant may remain intact and correctly positioned even though the breast appears lower, less full, more rippled, or different in proportion.
Miss Anca Breahna, PhD, MSc, FEBOPRAS, FRCS (Plast), Consultant Plastic & Reconstructive Surgeon in North West England, explains that menopause affects the tissues around breast implants rather than the implants themselves. Breast implants do not undergo hormonal change, but the skin, fat, glandular tissue, and support structures surrounding them may alter during perimenopause and menopause.
Many women enter menopause several years after their original breast augmentation. An implant that appeared balanced in the thirties may look different in the forties, fifties, or sixties because the breast envelope has aged, softened, or changed in volume. This does not automatically mean that the implant has ruptured, moved, or become unsafe.
Perimenopause can also cause fluctuating breast tenderness, temporary fullness, and changes in sensitivity. Some women notice that their bras no longer fit properly, their cleavage looks different, or the implant edges are easier to feel. Others become concerned because one breast appears lower or firmer than the other.
A careful consultation is important because several issues can produce similar symptoms. Hormonal breast tenderness, age-related sagging, implant rippling, capsular contracture, rupture, weight change, and unrelated breast conditions may all affect how the breasts look or feel. Miss Anca Breahna assesses the whole clinical picture before recommending reassurance, imaging, monitoring, or treatment.
Menopause does not normally make silicone or saline implants swell, shrink, or deteriorate suddenly. Most visible changes occur because the skin and natural breast tissue surrounding the implant become softer, thinner, less elastic, or differently distributed.
Common changes include:
The implant may therefore remain intact and stable while the breast envelope changes around it. Sudden swelling, rapid enlargement, a new lump, or persistent pain should not be assumed to be caused by menopause.
The breast can appear lower because ageing skin and connective tissues provide less support over time. Natural breast tissue may descend over a stable implant, changing the nipple position and the overall balance of the breast.
Signs of tissue descent may include:
These changes usually reflect stretching of the breast envelope rather than true implant displacement. A clinical examination can determine whether the concern is primarily sagging, implant movement, or a combination of both.
Falling and fluctuating hormone levels can change the composition, sensitivity, and volume of the natural breast tissue. The implant does not respond to hormones, but the surrounding tissue may become softer, less dense, temporarily fuller, or more tender.
Hormonal influences may include:
These changes vary considerably between women and may affect both breasts differently. Persistent, worsening, or one-sided symptoms should still be professionally assessed.
Weight gain or weight loss can alter the amount of natural tissue covering an implant. Even when the implant itself remains unchanged, the breasts may look larger, smaller, heavier, or more visibly augmented.
Weight-related changes may cause:
Most menopause-related breast changes are gradual and benign, but some symptoms require assessment. New, persistent, one-sided, or rapidly progressing changes should not be dismissed as hormonal.
Seek medical review for:
These symptoms can have many possible causes, and most do not indicate a serious condition. Prompt assessment allows appropriate imaging, reassurance, or treatment when necessary.
A detailed medical history helps distinguish hormonal and age-related changes from possible implant complications. Miss Anca Breahna reviews the original surgery, current symptoms, general health, and any factors that may influence breast shape or recovery.
The consultation usually covers:
Implant records are useful but are not essential for the consultation to proceed. Operation notes, implant cards, previous imaging, and clinic letters can provide helpful background when available.
The way symptoms develop can provide important clues about their likely cause. Intermittent tenderness affecting both breasts may be more consistent with hormonal change, while progressive one-sided firmness or swelling may require further investigation.
Useful details include:
Symptoms must always be considered alongside examination findings and implant history. The pattern does not establish a diagnosis by itself, but it helps guide the next steps.
Standardised clinical photographs document breast shape, symmetry, skin quality, and implant position. They create an accurate visual record that supports assessment, treatment planning, and future comparison.
Photographs may show:
Images are usually taken from front, side, and oblique angles in consistent lighting. This allows subtle differences to be evaluated more reliably than through casual photographs or mirror inspection.
Clinical photographs can make it easier to separate tissue ageing from implant movement. They may show that the implant remains relatively stable while the natural breast and nipple sit lower than before.
Photographic comparison can help identify:
This visual information supports a clearer discussion between patient and surgeon. All clinical images are stored confidentially as part of the medical record.
Breast measurements provide objective information about skin laxity, tissue descent, symmetry, and implant position. They help determine whether the main concern is ageing tissue, sagging, implant displacement, or a combination of issues.
Measurements may include:
These measurements help guide decisions about observation, breast uplift, implant exchange, implant removal, or combined surgery. They are always interpreted alongside symptoms, clinical photographs, implant history, and patient goals.
The thickness of the tissue covering the implant affects how visible or palpable the device may become. Reduced coverage can make rippling, edges, or contour irregularities more noticeable, particularly after weight loss or age-related tissue thinning.
Thin tissue coverage may influence:
Tissue thickness does not determine treatment on its own. Miss Anca Breahna considers it together with implant position, breast shape, skin quality, symptoms, and the patient’s preferred outcome.
The consultation brings together your medical history, photographs, measurements, symptoms, and treatment goals. Miss Anca Breahna uses this information to explain whether the changes are likely to be hormonal, age-related, implant-related, or caused by several factors together.
The discussion usually includes:
The purpose of the consultation is not to push every patient towards surgery. Some women need reassurance and monitoring, while others may benefit from a carefully planned revision procedure.
Normal ageing tends to produce gradual changes in both breasts, while implant complications may cause more localised, progressive, or one-sided symptoms. A diagnosis is based on examination, implant history, symptom pattern, and imaging when necessary.
Features more consistent with normal ageing may include:
Possible implant-related concerns may include increasing firmness, sudden swelling, visible distortion, or a rapidly developing asymmetry. Even so, no single symptom confirms a complication, which is why a formal assessment is important.
Breast imaging may be advised when there is concern about implant integrity, a new breast symptom, or an unclear examination finding. The most appropriate test depends on whether the aim is to assess natural breast tissue, the implant, or both.
Possible investigations include:
Breast cancer screening and implant-integrity assessment are not the same process. Patients should always tell the radiographer that they have implants so the examination can be adapted appropriately.
Treatment depends on the cause of the change, the condition of the implants, the quality of the tissues, and the patient’s goals. Options range from observation and supportive measures to uplift, implant exchange, implant removal, or combined revision surgery.
Potential options include:
No single procedure is suitable for every patient. Miss Anca Breahna develops a proportion-led plan that considers comfort, breast health, scarring, recovery, and the desired long-term shape.
Observation may be appropriate when the implants appear stable and the changes are mild, expected, and not causing significant distress. Menopause alone is not a reason to replace or remove breast implants.
Observation may be suitable when:
Monitoring can include symptom awareness, routine breast screening, and review if a new change develops. Choosing not to have surgery is a valid option when there is no medical or personal reason to proceed.
A correctly fitted bra can improve comfort and appearance when menopause-related changes are modest. It may reduce strain, improve support during exercise, and help patients understand whether the concern is mainly functional or structural.
Supportive measures may include:
These measures cannot correct significant loose skin, implant displacement, or capsular contracture. However, they may provide meaningful relief when the implant is healthy and surgery is neither necessary nor desired.
A breast uplift may be recommended when the principal problem is loose skin, breast descent, or a low nipple position. The procedure reshapes the natural breast envelope and repositions the nipple without necessarily changing the implant.
A breast uplift may address:
An uplift may be performed with the existing implants, with implant exchange, or after implant removal. The recommended approach depends on implant condition, tissue quality, breast volume, and the desired outcome.
Implant exchange may be appropriate when the existing device no longer suits the patient’s body, goals, or breast tissues. It may also be considered when there is confirmed rupture, significant implant malposition, capsular contracture, or a desire to change size.
Implant exchange can address:
Changing the implant alone may not correct loose skin or a low nipple position. In those cases, implant exchange may need to be combined with a breast uplift for a more balanced result.
Yes, implants can be removed without inserting new ones. This option may appeal to women who no longer want implants, prefer a smaller breast shape, or wish to avoid future implant-related monitoring and surgery.
Implant removal may be considered when:
The breast may look smaller, softer, or emptier after removal, especially when the skin has stretched. A breast uplift or fat transfer may be discussed if additional reshaping or volume support is required.
Fat transfer to breasts may improve tissue coverage, contour irregularities, or visible implant rippling in selected patients. Fat is taken from another area of the body and carefully placed around the breast to soften transitions and improve coverage.
Fat transfer may help with:
Fat transfer is not suitable for every patient and cannot replace an uplift when substantial loose skin is present. Some transferred fat is naturally reabsorbed, so the final retained volume may be less than the amount initially placed.
Capsular contracture occurs when the scar capsule around an implant tightens and changes the breast’s feel, shape, or comfort. Mild cases may be observed, while painful or visibly distorted breasts may require surgery.
Possible signs include:
Treatment may involve removal or modification of the capsule, implant exchange, pocket adjustment, or implant removal. The exact plan depends on the severity of the contracture, implant history, tissue condition, and patient preference.
Breast implant revision surgery has many of the same general risks as primary breast surgery, with additional complexity from scar tissue and previous anatomical changes. Risks vary according to whether the operation involves an uplift, implant exchange, capsule surgery, fat transfer, or implant removal.
Possible risks include:
A careful consultation should include a clear discussion of both common and uncommon complications. Miss Anca Breahna explains how individual factors such as smoking, medical conditions, implant history, and tissue quality may affect risk.
Recovery depends on the extent of surgery and whether an uplift, capsule procedure, or implant exchange is performed. Most patients experience swelling, tightness, bruising, and temporary discomfort during the early healing period.
A typical recovery may include:
Recovery instructions are personalised because revision procedures vary considerably. Patients should follow their surgeon’s advice rather than relying on a standard timetable from a previous operation.
Revision surgery can provide long-lasting improvement, but it does not stop ageing, hormonal change, or future weight fluctuations. Implants are not lifetime devices, and the surrounding breast tissues will continue to change over time.
Longevity is influenced by:
A stable weight and appropriate breast support may help preserve the result. Future monitoring remains important, particularly if silicone implants are retained or exchanged.
"*" indicates required fields
Preparing questions in advance can help you make a more confident and informed decision. The most useful questions focus on diagnosis, treatment alternatives, expected outcomes, recovery, and long-term follow-up.
Consider asking:
A good consultation should leave you with a clear understanding of your options and their limitations. You should not feel pressured to make a decision on the day.
The next step depends on whether the examination suggests normal ageing, a cosmetic concern, or a condition requiring investigation. Some patients leave with reassurance, while others may need imaging, follow-up, or a personalised surgical plan.
The usual patient pathway may involve:
A second consultation may be appropriate before surgery so that questions can be revisited and consent confirmed. Treatment should proceed only when the patient feels informed, comfortable, and clear about the likely benefits and limitations.
Hormonal tenderness often fluctuates and may affect both breasts, but any persistent, localised pain, new swelling, or a rapid shape change should be assessed. Screening does not evaluate implant integrity, so symptom-led assessment may involve different imaging.
Menopause itself is not listed as a direct cause, but changes in tissue, inflammation, and overall health factors can influence how breasts feel over time. Research highlights modifiable risk factors like smoking, oversizing, and hematoma, which matter more than menopausal status alone.
Implants add volume and weight, and if tissue support reduces with age, breast sagging can become more noticeable. The key is whether the change is mainly tissue support, implant size choice, or both, which is best assessed in consultation.
No. Implants do not swell with hormones, but your natural tissue can change in tenderness and fluid content. If symptoms are significant or unilateral, it is sensible to seek assessment rather than assume it is only HRT.
Attend the screening as invited and tell the radiographer you have implants. UK guidance explains that additional views are taken and techniques are adapted to show as much tissue as possible.
Routine replacement purely because of menopause is not recommended in the guidance. Monitoring and symptom awareness are emphasised, and implant decisions should be based on your implant age, symptoms, and goals, not a life stage alone.
New persistent swelling, a new lump, rapid change in breast size, persistent pain, or new underarm swelling should be assessed promptly. UK regulator information on BIA-ALCL explains the importance of symptom awareness.
Breast implants do not go through menopause, but your breast tissue and skin do. During perimenopause and menopause, it is common to notice changes in shape, bra fit, tenderness, or tissue drape, and those changes can make implants look different even when the implant itself is fine. UK screening remains available with implants, but it uses adapted techniques and you should always tell the radiographer that you have implants.
If you are noticing changes in your breasts during menopause and want clear, expert guidance, book a consultation with Miss Anca Breahna in North West England. Send an online enquiry via our contact page, or a photo via the site’s Complimentary Photo Assessment feature to build your confidence as you schedule a consultation. During your consultation, you will:
Miss Anca Breahna can help you understand what is normal, what needs checking, and what options actually help, from reassurance and monitoring to a tailored surgical plan when it is genuinely the best fit.
👉 Start here: Contact Anca Breahna Plastic Surgeon
Miss Breahna performs breast implant removal, replacement and capsulectomy in Chester for patients who wish to change their implants or who are experiencing concerns such as capsular contracture, rupture, malposition or changes in breast appearance. Treatment may involve implant removal alone, implant exchange, removal of the surrounding capsule where clinically appropriate, or additional revision of the breast pocket. During consultation, she considers the condition of the implants, the capsule, breast shape, skin quality and the patient’s current goals before recommending a tailored surgical plan. As an experienced plastic surgeon in Chester, she also discusses whether a breast uplift or other corrective procedure may be beneficial when implants are removed or exchanged.